Searched for
NOVAVAX
Novavax awaits FDA decision on whether its next COVID shot can be offered in USNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator tol...- Novavax soars 146% on $1.2 billion Sanofi vaccine licensing dealThe pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...
- France's Sanofi signs COVID-19 vaccine deal with NovavaxSanofi and Novavax partnered for a COVID-19 vaccine deal. Novavax will receive $1.2 billion in milestones. Sanofi will take an equity stake...
- Two large phase-3 trials of Novavax's COVID-19 vaccine show high levels of protection against infection: Research headSII and Novavax are the key partners in the development and manufacturing of the Novavax vaccine, marketed by Novavax as Nuvaxovid and by S...
- Novavax shares skyrocketed as FDA recommends the Vaccine for Covid19 in the U.SProtein-based covid shot, Novavax has received a recommendation by US Food and drug administration(FDA), which can make it the 4th option f...
- Novavax says COVID vaccine triggers immune response to Omicron variantNovavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization.
- EU approves 5th COVID-19 vaccine for bloc, one by NovavaxThe Novavax shot joins those from Pfizer-BioNTech, Moderna, Johnson & Johnson and AstraZeneca in the EU's vaccine armory.
- Novavax files for emergency use listing of COVID-19 vaccine with WHOEarlier on Monday, Novavax and its partner Serum Institute of India (SII) had said that they had received the first emergency use authorisa...
- Novavax and the recombinant protein vaccine: What you need to knowThe recombinant protein vaccine develops the body’s immunity against the coronavirus by using the virus' spike proteins. Used by Novavax in...
- Novavax set for India launch with Serum Institute as manufacturing partnerThe large Novavax trials conducted on 29,960 persons in the US and Mexico have delivered results that equal the Pfizer and Moderna jabs and...
- Novavax: Large study finds COVID-19 shot about 90% effectiveWhile demand for COVID-19 shots in the US has dropped off dramatically, the need for more vaccines around the world remains critical. The N...
- Will meet vaccine delivery goals by second half of 2021: NovavaxSerum Institute, which has signed up to manufacture upto 1 billion doses of Novavax's vaccine, is expected to file for approval in India in...
- Serum’s launch of Novavax shot in India may face delayAdar Poonawalla had complained in the past that the manufacturing of the Novavax vaccine was getting delayed due to a shortage of raw mater...
- GAVI inks pact with Serum Institute of India, Novavax for Covid-19 vaccine supplyThe Novavax vaccine has shown 90% efficacy in phase 3 clinical trials in the UK that enrolled more than 15,000 participants aged 18-84 year...
- Booster shot for India: Novavax vaccine shows 90% efficacy, J&J 66%Novavax said its NVX-CoV2373 demonstrated a 90% efficacy in phase 3 trials in the UK, taking it closer to approval by the UK health authori...
- Serum Institute to try out Novavax vaccine in October in partnership with ICMRThe trials of the glycoprotein subunit nanoparticle adjuvanted vaccine developed by Novavax will be led by ICMR-National AIDS Research Inst...
- Novavax aims for 2 bn COVID-19 vaccine doses with expanded India dealU.S. drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses ...
- Serum Institute inks deal to produce US-based biotech firm Novavax’s Covid vaccineThe Serum Institute of India (SII) will buy the vaccine components from Novavax and the two companies will equally split the revenue from t...
- Cadila Pharmaceuticals and Novavax to develop malaria vaccine using virus like particle technologyCadila Pharma and Novavax to develop new malaria vaccine using VLP technology. ICGEB also to partner them in the project.
- Novavax, Cadila form JV for developing vaccinesUS-based biotechnology firm Novavax has formed a joint venture with Cadila Pharmaceuticals for developing and commercialising virus-like pa...
Load More
